| Identification | Back Directory | [Name]
Methyl (6S)-4-[4′-[[[[4-[[(3-cyano-4-methyl-1H-indol-7-yl)amino]sulfonyl]phenyl]methyl]amino]carbonyl][1,1′-biphenyl]-4-yl]-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetate | [CAS]
2684292-71-3 | [Synonyms]
PROTAC BRD4 Degrader-19
Methyl (6S)-4-[4′-[[[[4-[[(3-cyano-4-methyl-1H-indol-7-yl)amino]sulfonyl]phenyl]methyl]amino]carbonyl][1,1′-biphenyl]-4-yl]-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetate | [Molecular Formula]
C44H38N8O5S2 | [MOL File]
2684292-71-3.mol | [Molecular Weight]
822.96 |
| Hazard Information | Back Directory | [Uses]
PROTAC BRD4 Degrader-19 (compound 176) is a PROTAC that targets BRD4 protein for degradation. PROTAC BRD4 Degrader-19 can be used in cancer research[1]. | [References]
[1] Ohba Kiyomi, et al. Medicine containing BRD4 protein degradation inducer. JP2023024381. |
|
|